Cerevel Therapeutics Holdings Stock Market Value
| CERE Stock | USD 41.00 0.33 0.80% |
| Symbol | Cerevel |
Cerevel Therapeutics Price To Book Ratio
Is Cerevel Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cerevel Therapeutics. If investors know Cerevel will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cerevel Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.71) | Return On Assets (0.30) | Return On Equity (0.92) |
The market value of Cerevel Therapeutics is measured differently than its book value, which is the value of Cerevel that is recorded on the company's balance sheet. Investors also form their own opinion of Cerevel Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Cerevel Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cerevel Therapeutics' market value can be influenced by many factors that don't directly affect Cerevel Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cerevel Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Cerevel Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cerevel Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cerevel Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Cerevel Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Cerevel Therapeutics.
| 04/30/2024 |
| 05/30/2024 |
If you would invest 0.00 in Cerevel Therapeutics on April 30, 2024 and sell it all today you would earn a total of 0.00 from holding Cerevel Therapeutics Holdings or generate 0.0% return on investment in Cerevel Therapeutics over 30 days. Cerevel Therapeutics is related to or competes with MicroAlgo, Morningstar Unconstrained, T Rowe, Nt International, Malaga Financial, Americold Realty, and SEI Investments. Cerevel Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, engages in the development of various t... More
Cerevel Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Cerevel Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Cerevel Therapeutics Holdings upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 0.3861 | |||
| Information Ratio | (0.07) | |||
| Maximum Drawdown | 2.02 | |||
| Value At Risk | (0.67) | |||
| Potential Upside | 0.788 |
Cerevel Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Cerevel Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Cerevel Therapeutics' standard deviation. In reality, there are many statistical measures that can use Cerevel Therapeutics historical prices to predict the future Cerevel Therapeutics' volatility.| Risk Adjusted Performance | 0.0039 | |||
| Jensen Alpha | (0.01) | |||
| Total Risk Alpha | (0.02) | |||
| Sortino Ratio | (0.08) | |||
| Treynor Ratio | (0.04) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Cerevel Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Cerevel Therapeutics Backtested Returns
Cerevel Therapeutics secures Sharpe Ratio (or Efficiency) of -0.0023, which signifies that the company had a -0.0023% return per unit of risk over the last 3 months. Cerevel Therapeutics Holdings exposes thirty different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Cerevel Therapeutics' Downside Deviation of 0.3861, risk adjusted performance of 0.0039, and Mean Deviation of 0.3324 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 0.12, which signifies not very significant fluctuations relative to the market. As returns on the market increase, Cerevel Therapeutics' returns are expected to increase less than the market. However, during the bear market, the loss of holding Cerevel Therapeutics is expected to be smaller as well. Cerevel Therapeutics has an expected return of -0.001%. Please make sure to confirm Cerevel Therapeutics treynor ratio, kurtosis, period momentum indicator, as well as the relationship between the downside variance and day median price , to decide if Cerevel Therapeutics performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.87 |
Very good predictability
Cerevel Therapeutics Holdings has very good predictability. Overlapping area represents the amount of predictability between Cerevel Therapeutics time series from 30th of April 2024 to 15th of May 2024 and 15th of May 2024 to 30th of May 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Cerevel Therapeutics price movement. The serial correlation of 0.87 indicates that approximately 87.0% of current Cerevel Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.87 | |
| Spearman Rank Test | 0.93 | |
| Residual Average | 0.0 | |
| Price Variance | 0.22 |
Cerevel Therapeutics lagged returns against current returns
Autocorrelation, which is Cerevel Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Cerevel Therapeutics' stock expected returns. We can calculate the autocorrelation of Cerevel Therapeutics returns to help us make a trade decision. For example, suppose you find that Cerevel Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Cerevel Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Cerevel Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Cerevel Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Cerevel Therapeutics stock over time.
Current vs Lagged Prices |
| Timeline |
Cerevel Therapeutics Lagged Returns
When evaluating Cerevel Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Cerevel Therapeutics stock have on its future price. Cerevel Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Cerevel Therapeutics autocorrelation shows the relationship between Cerevel Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in Cerevel Therapeutics Holdings.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Cerevel Therapeutics is a strong investment it is important to analyze Cerevel Therapeutics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Cerevel Therapeutics' future performance. For an informed investment choice regarding Cerevel Stock, refer to the following important reports:Check out Cerevel Therapeutics Correlation, Cerevel Therapeutics Volatility and Cerevel Therapeutics Alpha and Beta module to complement your research on Cerevel Therapeutics. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Complementary Tools for Cerevel Stock analysis
When running Cerevel Therapeutics' price analysis, check to measure Cerevel Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cerevel Therapeutics is operating at the current time. Most of Cerevel Therapeutics' value examination focuses on studying past and present price action to predict the probability of Cerevel Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cerevel Therapeutics' price. Additionally, you may evaluate how the addition of Cerevel Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |
Cerevel Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.